Arrowhead PharmaceuticalsARWR 
$21.86-1.26%24h
-1.26%24h
Global rank4342
Market cap$2.33B
Change 7d-7.65%
YTD Performance-28.33%
SP500 benchmarkUnderperform
P/E-11.39
P/S9.69
Revenue$240.74M
Earnings-$209.28M
Dividend yield-
Main Sector
Healthcare
Arrowhead Pharmaceuticals (ARWR) Cash on Hand
ARWR Cash on Hand in 2022: $403.63M
According to Arrowhead Pharmaceuticals latest financial reports the cash on hand of ARWR is $403.63M, an increase of 7.23% to 2022. At the end of 2022 company had $376.40M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
ARWR Cash on Hand History from 2018 to 2023
-
Value:-
ARWR Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $403.63M | 7.23% |
| 2022 | $376.40M | 2.34% |
| 2021 | $367.79M | 16.58% |
| 2020 | $315.49M | 21.95% |
| 2019 | $258.70M | 238.03% |
| 2018 | $76.53M | - |
View the Top Cash on Hand Companies 
